Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Aligos Therapeutics, Inc. (NASDAQ: ALGS)
ALGS Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-11.40%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
400%
ALGS Stock Analysis
ALGS
PE Ratio:
ALGS
PEG Ratio:
Not Available
ALGS
Forward EPS Growth (12 month):
0.00%
ALGS
PS Ratio:
6.8
ALGS
PSG Ratio:
-1.1
ALGS
Forward Revenue Growth (12 month):
-6.00%
ALGS Articles
No data was found